Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Individuals who undergo spine surgery often have a significant loss of blood and may require
multiple blood transfusions. Research has shown that epsilon-aminocaproic acid (EACA) may
reduce the amount of blood lost during surgery, which would decrease the number of blood
transfusions required. This study will evaluate the safety and effectiveness of EACA at
reducing blood loss and the need for blood transfusions in individuals undergoing spine
surgery.